SCHEMBL6981343

SCHEMBL6981343

O=c1[nH]c2ccccc2c(=O)n1-c1cccc(C(F)(F)F)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.67
KDM4E B2RXH2 2/20 0.67
TP53 P04637 3/20 0.58
NPSR1 Q6W5P4 2/20 0.54
HSP90AA1 P07900 1/20 0.53
LMNA P02545 3/20 0.52
MAPT P10636 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
MAPK1 P28482 1/20 0.52
HTT P42858 1/20 0.52
NPEPPS P55786 2/20 0.51
CCKBR P32239 1/20 0.51
CYP1A2 P05177 1/20 0.50
PMM2 O15305 1/20 0.50
MPI P34949 1/20 0.50
PHOSPHO1 Q8TCT1 1/20 0.50
TRPV1 Q8NER1 1/20 0.48
ABCB11 O95342 1/20 0.47
HTR1A P08908 1/20 0.47
ADRA2A P08913 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6981971 0.89 KDM4E (0.58) GAAKDM4ETP53NPSR1HSP90AA1
SCHEMBL6976175 0.85 TRPV1 (0.62) GAAKDM4ETP53HSP90AA1SMN1; SMN2
SCHEMBL6981508 0.82 KDM4E (0.72) GAAKDM4ETP53LMNASMN1; SMN2
SCHEMBL6980347 0.80 KDM4E (1.00) GAAKDM4ETP53NPSR1HSP90AA1
SCHEMBL6981446 0.79 KDM4E (0.71) GAAKDM4ETP53LMNASMN1; SMN2
SCHEMBL6975203 0.79 KDM4E (0.72) GAAKDM4ETP53SMN1; SMN2HTT
SCHEMBL10999663 0.78 GSR (0.52) GAAKDM4EHSP90AA1HTTCYP1A2
SCHEMBL5534269 0.78 CYP1A2 (0.54) GAALMNAMAPTMAPK1HTT
SCHEMBL1083272 0.77 MTOR (0.51) GAALMNAHTTCCKBRCYP1A2
SCHEMBL6979777 0.77 KDM4E (0.68) GAAKDM4ETP53LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030199530-A1 New compounds derived from quinazoline LES LABORATORIES SERVIER (FR) 2003-10-23 US disclosed
EP-1346992-A1 Quinazoline derivatives, process for their preparation and pharmaceutical compositions containing them Les Laboratoires Servier (FR) 2003-09-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030199530-A1 New compounds derived from quinazoline NQO2, XDH, DRD1 GAA 638/4885KDM4E 4217/4885TP53 3198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.